Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis, Delta”

120 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 120 results

Large-scale testing (Phase 3)Study completedNCT01595685
What this trial is testing

Telbivudine Versus Entecavir in Reducing Serum HBsAg Levels in Patients With HBeAg-positive Chronic Hepatitis B

Who this might be right for
Chronic Viral Hepatitis B Without Delta-agent
Asan Medical Center 98
Testing effectiveness (Phase 2)WithdrawnNCT05953545
What this trial is testing

Peginterferon Lambda and Lonafarnib Boosted With Ritonavir 48-Week Combination Therapy for Delta Hepatitis

Who this might be right for
Chronic Hepatitis Delta
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Large-scale testing (Phase 3)Study completedNCT03719313
What this trial is testing

Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2a

Who this might be right for
Hepatitis Delta Virus
Eiger BioPharmaceuticals 407
Not applicableWithdrawnNCT06068140
What this trial is testing

Evaluation of the Effectiveness of the Complex of Carnitine Orotate and Biphenyl Dimethyl Dicarboxylate in the Adjuvant Therapy of Chronic Hepatitis D in Real Clinical Practice: a Prospective Cohort Study

Who this might be right for
Chronic Viral Hepatitis B With Delta-Agent
Kazakh Association of Internal Medicine Specialists
Early research (Phase 1)Study completedNCT02259855
What this trial is testing

Pharmacokinetics (PK) of Tipranavir/Ritonavir, Ribavirin, Pegylated Interferon (Peg INF) in Hepatitis C (HCV) Subjects With Mild Hepatic Impairment and in HCV, Hepatitis B (HBV), Hepatitis D Infected Subjects or Alcoholic Cirrhosis With Moderate Hepatic Impairment

Who this might be right for
Hepatic Insufficiency
Boehringer Ingelheim 36
Not applicableLooking for participantsNCT00001971
What this trial is testing

Evaluation of Patients With Liver Disease

Who this might be right for
Hepatitis DHepatitis CHepatitis B+1 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 8,050
Testing effectiveness (Phase 2)Study completedNCT02430194
What this trial is testing

Lonafarnib Boosted With Ritonavir With and Without Peginterferon Alfa-2a (PEG IFN-a) in HDV (LOWR-2)

Who this might be right for
Chronic Hepatitis D Infection
Eiger BioPharmaceuticals 55
Post-approval studies (Phase 4)Ended earlyNCT01264094
What this trial is testing

Evaluate the Efficacy and the Change of sAg Levels in Chronic Hepatitis B Patients Receiving Clevudine Treatment Over the Long Period

Who this might be right for
Chronic Hepatitis B
Bukwang Pharmaceutical 200
Not applicableUnknownNCT05181956
What this trial is testing

Testing and Epidemiology of Delta Hepatitis

Who this might be right for
Chronic Hepatitis D Infection With Hepatitis B
Asian Pacific Liver Center at Coalition of Inclusive Medicine 5,000
Testing effectiveness (Phase 2)Study completedNCT00023322
What this trial is testing

Pegylated Interferon to Treat Chronic Hepatitis D

Who this might be right for
Hepatitis D
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 13
Not applicableStudy completedNCT04038372
What this trial is testing

Hepatitis D Virus Infection Among Hepatitis B Virus Surface Antigen Positive Individuals

Who this might be right for
HDV InfectionHBV Infection
Assiut University 186
Not applicableUnknownNCT06111859
What this trial is testing

Effectiveness of Ultrasound in Liver Stiffness and Fat Quantification

Who this might be right for
Liver Disease ChronicFibrosis, LiverLiver Steatoses+4 more
King's College Hospital NHS Trust 180
Not applicableNot Yet RecruitingNCT06649396
What this trial is testing

Determination of New Detection and Quantification Thresholds for Serological and Molecular Tests for Hepatitis Delta Virus (HDV) Using Capillary Blood on Blotting Paper (DBS)

Who this might be right for
Delta Hepatitis
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba 120
Testing effectiveness (Phase 2)WithdrawnNCT02968641
What this trial is testing

Lonafarnib With or Without Ritonavir in Patients With HDV

Who this might be right for
Chronic Delta Hepatitis
Eiger BioPharmaceuticals
Not applicableLooking for participantsNCT04166266
What this trial is testing

National Cohort of Patients Co-infected With Hepatitis B and Delta Viruses

Who this might be right for
Hepatitis D, ChronicHepatitis B, Chronic
ANRS, Emerging Infectious Diseases 800
Post-approval studies (Phase 4)Study completedNCT01639066
What this trial is testing

Tenofovir Plus Entecavir vs. Tenofovir in Adefovir-Resistant Chronic Hepatitis B

Who this might be right for
Chronic Viral Hepatitis B Without Delta-agent
Asan Medical Center 102
Not applicableLooking for participantsNCT06504485
What this trial is testing

Immunological and Virological Characterization of Patients With Chronic HBV-HDV Infection: Outcomes and Response to Bulevirtide Treatment

Who this might be right for
Hepatitis D
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 192
Not applicableUnknownNCT02797782
What this trial is testing

Study of the Long Term Efficacy of Recombinant Hepatitis B Vaccine in Nile Delta of Egypt

Who this might be right for
Hepatitis B Vaccines
Sherief Abd-Elsalam 200
Not applicableStudy completedNCT05002907
What this trial is testing

Epidemiology of Hepatitis B, C and D and HIV Along the Maroni River Bordering French Guiana and Suriname (MaHeVi)

Who this might be right for
Hepatitis BHepatitis CHepatitis D+3 more
Centre Hospitalier de Cayenne 2,289
Not applicableStudy completedNCT03908294
What this trial is testing

Change of Glucose Metabolism and Fibrosis Markers in Patients With Hepatitis C Under Treatment With Antiviral Agents

Who this might be right for
Glucose Metabolism DisordersLiver FibrosisHepatitis C
Johann Wolfgang Goethe University Hospital 46
Load More Results